%20CO.%2C%20LTD./other/CHANGCHUN_HIGH-TECH_INDUSTRY_GROUP__inq51an.png)
CHANGCHUN HIGH-TECH INDUSTRY (GROUP) CO., LTD. — Investor Relations & Filings
CHANGCHUN HIGH-TECH INDUSTRY (GROUP) CO., LTD. is a diversified enterprise primarily focused on the research, development, production, and distribution of biopharmaceuticals and healthcare products. The company operates through several key subsidiaries, most notably GeneScience Pharmaceuticals, which specializes in recombinant human growth hormones and pediatric endocrinology treatments. Its product portfolio includes biological drugs, vaccines, and traditional Chinese medicines, targeting therapeutic areas such as growth disorders, infectious diseases, and oncology. The group emphasizes technological innovation and maintains a significant presence in the domestic market while expanding its international footprint. In addition to its core life sciences business, the company maintains interests in real estate development and infrastructure management.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 第九届董事会第三十一次会议决议公告 | 2021-01-25 | Chinese | |
| 关于监事辞职及补选监事的公告 | 2021-01-25 | Chinese | |
| 关于召开2021年第一次临时股东大会的通知 | 2021-01-25 | Chinese | |
| 关于部分董事、高级管理人员减持股份预披露公告 | 2021-01-11 | Chinese | |
| 2020年度业绩预告 | 2021-01-05 | Chinese | |
| 中信建投证券股份有限公司、中天国富证券有限公司关于公司发行股份及可转换债券购买资产并募集配套资金暨关联交易之募集配套资金新增股份解除限售的核查意见 | 2021-01-04 | Chinese |
Browse filings by year
27 years- 2026 57 filings
- 2025 176 filings
- 2024 162 filings
- 2023 131 filings
- 2022 139 filings
- 2021 152 filings
- 2020 157 filings
- 2019 238 filings
- 2018 124 filings
- 2017 95 filings
- 2016 102 filings
- 2015 122 filings
- 2014 98 filings
- 2013 75 filings
- 2012 80 filings
- 2011 46 filings
- 2010 57 filings
- 2009 47 filings
- 2008 33 filings
- 2007 42 filings
- 2006 48 filings
- 2005 26 filings
- 2004 29 filings
- 2003 27 filings
- 2002 17 filings
- 2001 7 filings
- 1996 1 filing
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2021
7 filings
| |||||
| 42957498 | 第九届董事会第三十一次会议决议公告 | 2021-01-25 | Chinese | ||
| 42957465 | 关于监事辞职及补选监事的公告 | 2021-01-25 | Chinese | ||
| 42957366 | 关于召开2021年第一次临时股东大会的通知 | 2021-01-25 | Chinese | ||
| 42957314 | 关于部分董事、高级管理人员减持股份预披露公告 | 2021-01-11 | Chinese | ||
| 42957276 | 2020年度业绩预告 | 2021-01-05 | Chinese | ||
| 42957242 | 中信建投证券股份有限公司、中天国富证券有限公司关于公司发行股份及可转换债券购买资产并募集配套资金暨关联交易之募集配套资金新增股份解除限售的核查意见 | 2021-01-04 | Chinese | ||
| 42957208 | 关于发行股份及可转换债券购买资产并募集配套资金暨关联交易之募集配套资金新增股份解除限售的提示性公告 | 2021-01-04 | Chinese | ||
|
2020
8 filings
| |||||
| 42957168 | 关于第一大股东部分股份质押的公告 | 2020-12-29 | Chinese | ||
| 42957120 | 关于注销募集资金专项账户的公告 | 2020-12-24 | Chinese | ||
| 42957062 | 关于控股子公司金妥利珠单抗注射液获得美国FDA药物临床试验批准的公告 | 2020-12-18 | Chinese | ||
| 42957025 | 关于持股5%以上股东减持股份超过1%的公告 | 2020-12-17 | Chinese | ||
| 42956970 | 中信建投证券股份有限公司、中天国富证券有限公司关于公司发行股份及可转换债券购买资产并募集配套资金暨关联交易之部分限售股份上市流通的核查意见 | 2020-12-14 | Chinese | ||
| 42956932 | 关于发行股份及可转换债券购买资产之新增股份部分解除限售的提示性公告 | 2020-12-14 | Chinese | ||
| 42956911 | 关于子公司取得成都信立泰重组人促卵泡激素-CTP融合蛋白注射液相关权益的公告 | 2020-12-11 | Chinese | ||
| 42956871 | 关于子公司取得台湾逸达公司甲磺酸亮丙瑞林产品相关权益的公告 | 2020-11-17 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
CHANGCHUN HIGH-TECH INDUSTRY (GROUP) CO., LTD. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/53737/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=53737 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=53737 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=53737 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 53737}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for CHANGCHUN HIGH-TECH INDUSTRY (GROUP) CO., LTD. (id: 53737)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.